Experimental study on inhibitory effects of histone deacetylase inhibitor MS-275 and TSA on bladder cancer cells (Q39889318)

15 September 2017

Experimental study on inhibitory effects of histone deacetylase inhibitor MS-275 and TSA on bladder cancer cells (English)

1 reference

15 September 2017

1 reference

1 reference

Wei Qu

1

1 reference

15 September 2017

Yin-Dong Kang

2

1 reference

15 September 2017

Mei-Sheng Zhou

3

1 reference

15 September 2017

Li-Li Fu

4

1 reference

15 September 2017

Zhen-Hao Hua

5

1 reference

15 September 2017

Li-Ming Wang

6

1 reference

15 September 2017

31 January 2009

1 reference

15 September 2017

1 reference

15 September 2017

28

1 reference

15 September 2017

6

1 reference

15 September 2017

648-654

1 reference

Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

Epigenetics in human disease and prospects for epigenetic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

Histone modification enzymes: novel targets for cancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

p21--negative regulator of the cell cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

Histone deacetylase inhibitors specifically kill nonproliferating tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

Histone deacetylase inhibitors upregulate plakoglobin expression in bladder carcinoma cells and display antineoplastic activity in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

Antitumor effect of dsRNA-induced p21(WAF1/CIP1) gene activation in human bladder cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

Up-regulation of p21WAF1/Cip1 by saRNA induces G1-phase arrest and apoptosis in T24 human bladder cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

Cell cycle sibling rivalry: Cdc2 vs. Cdk2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

G1/S arrest induced by histone deacetylase inhibitor sodium butyrate in E1A + Ras-transformed cells is mediated through down-regulation of E2F activity and stabilization of beta-catenin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

The Bcl-2 apoptotic switch in cancer development and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

Killing cancer cells by flipping the Bcl-2/Bax switch.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

Valproic acid inhibits growth, induces apoptosis, and modulates apoptosis-regulatory and differentiation gene expression in human thyroid cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.11.018

10.1016/J.UROLONC.2008.11.018

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference